#1
|
|||
|
|||
Ëåéêîïåíèÿ ïðè ðåöèäèâå ÄÒÇ
Óâàæàåìûå êîëëåãè ïîäñêàæèòå ïîæàëóéñòà. Ïàöèåíòêà 31 ãîä, ÈÌÒ 20,9.  àíàìíåçå ÄÒÇ ñ 2010 ãîäà, òî÷íî áûë ðåöèäèâ 2014 â ãîäó, óòâåðæäàåò, ÷òî ïîñëåäíèå 5 ëåò ïðèíèìàåò òèðåîñòàòèêè â ìàëûõ äîçàõ ñ ïåðåðûâàìè ïî íåñêîëüêî ìåñÿöåâ.
â 2019 ãîäó âåðíóëàñü íà 5-2,5ìã òèðîçîëà â äåíü â òå÷åíèå íåñêîëüêèõ ìåñÿöåâ åñòü àíàëèçû îò 13.04.19 ÒÒà 0,2225, ñâÒ4 13,74(0,35-4,94), ÀÒ ê ðÒÒà 1,91++(ìåíåå 1,0), ÀÒ ê ÒÏÎ 66,62++ Îáðàòèëàñü ñ æàëîáàìè íà äðîæü âñåãî òåëà è ó÷àùåííîå ñåðäöåáèåíèå äî 114 óä\ìèí îò 02.08.2020 ÒÒà ìåíåå 0,0025--, ñâÒ4 40,55++, ñâÒ3 22,3++, ÀÒ ê ð ÒÒà 5,56(ìåíåå 1,0)ÑÎÝ 3, ýð 4,6,Íâ 116, Ãåìàòîêðèò 36, MCV 79,0(82,9-98), MCH 25,1(27-32,3), ÌÑÍÑ 32(31,8-34,7), ë 3,69(4,37-9,68), ÀËÒ 21,9, ÀÑÒ 25,9, êðåàòèíèí 45, ãëþ 4,73, áèë îáù 11,8 îò 01.08.20 ÓÇÈ ùèò æåë Îáúåì 20.71 ñì3 Çàêëþ÷åíèå:ÓÇ - ïðèçíàêè ôîêàëüíî-äèôôóçíûõ èçìåíåíèé ùèòîâèäíîé æåëåçû ïî òèïó õðîíè÷åñêîãî àóòîèììóííîãî òèðåîèäèòà. ÝÊà ðèòì ñèíóñîâûé, íîðìàëüíîå ïîëîæåíèå ÝÎÑ, ñèíóñîâàÿ àðèòìèÿ, îòðèöàòåëüíûå çÒ â V3-V5! Ðåêîìåíäîâàëà åé áèñîïðîëîë 5 ìã ïî 1 òàá 2 ðàçà â äåíü è ðåøåíèå âîïðîñà ÐÉÒ èëè õèðóðãè÷åñêîå ëå÷åíèå. Íî îíà çàâòðà ïîñëå êîíñóëüòàöèè ðàäèîëîãà ïðèäåò ñíîâà, âîçìîæíî îòêàæåòñÿ îò ðàäèêàëüíûõ ìåòîäîâ, ìîãó ëè ÿ íàçíà÷èòü òèðîçîë ñ ó÷åòîì ëåéêîïåíèè? Èëè ëó÷øå ïðîïèöèë? ëåéêîöèòû 3,69(4,37-9,68), íåéòðîôèëû 0,84(2-7,15), íåéòðîôèëû % 22,7(42,5-73,2), ýîç 0,1, ýîç% 2,7, áàçîô 0, ìîíîöèòû 0,6(0,29-0,71), ìîíîöèòû % 16,3(4,3-11), ëèìô 2,15(1,16-3,18), ëèìô%58,3(18,2-47,4) |
#2
|
||||
|
||||
ó íåå è àíåìèÿ, åñëè åòî æäà, òî åå êîððåêöèÿ ìîæåò íîðìàëèçîâàòü è ÷èñëî ëåéêîöèòîâ/íåéòðîôèëîâ
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#3
|
|||
|
|||
È òèðîçîë è ïðîïèöèë îáà âûçûâàþò ëåéêîïåíèþ.
Îíà óæå êàê ìèíèìóì îäèí ðàç âàì è ñåáå äîêàçàëà, ÷òî òèðîñòàòèêàìè åå Ãðåéâç íå âûëå÷èòü. À òóò åù¸ è íåéòðîôèëû ñ ÷åãî-òî âíèç ïîøëè... ß áû â áåñåäå ñ íåé ñäåëàë áû ìàêñèìàëüíî , ÷òîáû äàòü åé ðåàëüíóþ êàðòèíó, âîçìîæíûå îñëîæíåíèÿ è ïîçâîíèë áû ðàäèîëîãó ( îíè ó âàñ êîíòðîëèðóþò ÐÉÒ?). ß íå ïîíèìàþ, ïî÷åìó Âû äóìàåòå, ÷òî ðàäèîëîã ïîñîâåòóåò åé òàáëåòêè? ÐÉÒ ïðåäïî÷òèòåëåí: 0.2 mCi íà ãðàìì æåëåçû , ïîïðàâëåííûé íà àïòýéê ïðèêàí÷èâàåò Ãðåéâç â 90+% ñëó÷àåâ. Ïîêà äåðæàòü íà áåòà áëîêåðàõ, ñëåäèòü çà ÒÒà ðàç â ìåñÿö (25% óñïåõà â ïåðâûé ìåñÿö), åñëè íåò îòâåòà ÷åðåç 6 ìåñÿöåâ, òî äàòü åù¸ äîçó. Ýòî ñëó÷àåòñÿ ó ~7% áîëüíûõ, ïî÷òè èñêëþ÷èòåëüíî ëå÷åíûõ ïðîïèöèëîì â ïðîøëîì. Òàê ÷òî åù¸ îäíà ïðè÷èíà åãî íå ïðèìåíÿòü. Êîãäà ÒÒà ñòàíåò âûøå 10, íà÷àòü òèðîêñèí. Êîíåö âîëíåíèÿì íà âñþ æèçíü è øðàìà íà øåå íåò, è äðóãèõ õèðóðãè÷åñêèõ îñëîæíåíèé òîæå. Ñìîòðèòå òóò: Efficacy of radioactive iodine treatment of graves' hyperthyroidism using a single calculated (131)I dose. Wong KK, Shulkin BL, Gross MD, Avram AM. Clin Diabetes Endocrinol. 2018 Nov 28;4:20. doi: 10.1186/s40842-018-0071-6. eCollection 2018. PMID: 30505461 Free PMC article. The goal of RAI treatment was to achieve hypothyroidism within 3-6 months of (131)I administration. Response to RAI therapy was assessed at 7 weeks and 3 months by clinical and biochemical follow-up. ...CONCLUSION: Successful (131)I therapy for Graves' …
__________________
Dr.B |
#4
|
||||
|
||||
Äåéñòâèå ïðîèñõîäèò â Ìîñêâå, ÐÉ äîñòóïåí â ÝÍÖ, â ÍÈÈ ðàäèîëîãèè, ðÿäîì Îáíèíñê, åñòü îòäåëåíèå â Áîòêèíñêîé...
__________________
Ã.À. Ìåëüíè÷åíêî |
#5
|
|||
|
|||
Îêàçàëîñü, ÷òî çàïèñü íà ÐÉÒ â Íàó÷íûé öåíòð ðåíòãåíðàäèîëîãèè íà íà÷àëî îêòÿáðÿ.
|
#6
|
||||
|
||||
È ÷òî?
__________________
Ã.À. Ìåëüíè÷åíêî |
#7
|
|||
|
|||
Áóäåò åùå èñêàòü, ãäå ïðîéòè ïîðàíüøå. Ïîêà íàçíà÷èëè òàì ïðîïèöèë. Ñïàñèáî áîëüøîå.
|
|
#8
|
||||
|
||||
Íî ýíäîêðèíîëîã Âû- ïî÷åìó ïðîïèöèë?
__________________
Ã.À. Ìåëüíè÷åíêî |
#9
|
|||
|
|||
Êî ìíå îíà ïîêà íå äîøëà, ïî òåëåôîíó åé ðåêîìåíäîâàëà íå ïèòü òèðåîñòàòèêè, èñêàòü äðóãîå ìåñòî äëÿ ÐÉÒ.
Åñëè ïðèäåòñÿ äîëãî æäàòü ÐÉÒ, òîãäà ëó÷øå íàçíà÷èòü òèðîçîë 20 ìã\ñóò? |
#10
|
||||
|
||||
Äà, òàê
__________________
Ã.À. Ìåëüíè÷åíêî |
#11
|
|||
|
|||
 ïðèíöèïå, íè÷åãî ýêçîòè÷åñêîãî ìû èñêàòü íå äîëæíû: ëåéêîïåíèÿ ýòî èçâåñòíàÿ ìàíèôåñòàöèÿ òèðåîòîêñèêîçà. Åù¸ Êîõåð åãî îòìå÷àë êàê #1 èç ìàíèôåñòàöèé òèðåîòîêñèêîçà. Åãî è ëå÷èòü íàäî.
À ÷òî, â Ìîñêâå òðóäíî íàéòè ìåñòî ãäå ðàäèîèîä ìîãóò äàòü ñêîðåå, ÷åì â îêòÿáðå?
__________________
Dr.B |
#12
|
|||
|
|||
Ó íàñ ðàáîòàë â ßäåðíîé Ìåäèöèíå ä-ð Ñèññîí, ùèòîâèäêà áûëà åãî êîíüêîì.
Ïðè íåì ïðîòîêîë áûë òàêîé: - îòìåíèòü Ïðîïèöèë èëè òèðîçîë çà 5-7 äíåé äî ÐÉÒ - íà÷àòü ëèòèé 600-900 ìã/äåíü - äàòü ÐÉ - ÷åðåç 2 äíÿ íà÷àòü Òèðîçîë - îòìåíèòü ëèòèé íåäåëþ ïîñëå ÐÉ - îòìåíèòü Òèðîçîë ÷åðåç~ ìåñÿö - Ïðîâåðèòü ÒÒà ÷åðåç ìåñÿö-ïîëòîðà ïîñëå ýòîãî Ôèøêà áûëà â òîì, ÷òî ëèòèé áëîêèðóåò âûâåäåíèå éîäà èç ÙÇ - æåëåçà íàêàïëèâàåò åãî è ïîëó÷àåò áîëüøå ðàäèàöèè Òèðîçîë ïîñëå ÐÉ áëîêèðóåò ñèíòåç íîâîãî ãîðìîíà è óñêîðÿåò êëèíè÷åñêîå óëó÷øåíèå. Ðàáîòàëî ýòî ïðåêðàñíî. Ïîñëå ýòîãî åñòü ðàáîòû, ïîäòâåðæäàþùèå ýòîò ïðîòîêîë. % èçëå÷åíèÿ âûøå è áûñòðåå, áåç çíà÷èòåëüíûõ ïîáî÷åê Ê ïðèìåðó: Impact of Lithium on Efficacy of Radioactive Iodine Therapy for Graves’ Disease: A Cohort Study on Cure Rate, Time to Cure, and Frequency of Increased Serum Thyroxine After Antithyroid Drug Withdrawal Fausto Bogazzi, Clara Giovannetti, Rezene Fessehatsion, Maria Laura Tanda, Alberto Campomori, Emanuele Compri, Giuseppe Rossi, Claudia Ceccarelli, Paolo Vitti, Aldo Pinchera ... Show more The Journal of Clinical Endocrinology & Metabolism, Volume 95, Issue 1, 1 January 2010, Pages 201–208, [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ìîæíî, êîíå÷íî, âîçðàçèòü, ÷òî âìåñòî äîáàâëåíèÿ ëèòèÿ ìîæíî ïðîñòî äàòü áîëüøå ÐÉ. Íî ýòî ïîâûñèò ðàäèàöèîííûé ýôôåêò íà äðóãèå îðãàíû, â îñîáåííîñòè ïîëîâûå æåëåçû. Âñå ýòî òåîðåòè÷åñêè, êîíå÷íî. Åñòü åù¸ îäíî íàïðàâëåíèå: ïîñëå ÐÉ â äîçå 30 mCi è âûøå, áîëüíîãî íàäî îñòàâèòü â áîëüíèöå, â èçîëÿöèè, èçìåðÿòü ðàäèîàêòèâíîñòü ìî÷è è ïð. Òàê ÷òîáû îáîéòè ýòó áþðîêðàòèþ, åñòü ìåñòà , ãäå ïðîñòî äàþò 29.9 Çàêîí, îí êàê ñòîëá: ïåðåïðûãíóòü íåëüçÿ, à îáîéòè ëåãêî è ïðèÿòíî:-)))
__________________
Dr.B |
#13
|
||||
|
||||
Íàø ÏÎ Ðóìÿíöåâ òîæå ôàíàò ëèòèÿ, íî ó íåãî åù¸ êîíöåïöèÿ èíäèâèäóàëüíîãî ïîäáîðà ( ïîíÿòü ñèå ÿ íå î÷åíü ìîãó)
__________________
Ã.À. Ìåëüíè÷åíêî |
#14
|
||||
|
||||
Öèòàòà:
Äî îêòÿáðÿ îñòàëîñü äâà ñ ïîëîâèíîé ìåñÿöà Ìá, ëó÷øå â Áîòêèíñêîé èëè Îáíèíñêå
__________________
Ã.À. Ìåëüíè÷åíêî |
#15
|
||||
|
||||
ëèòèé òàêæå áëàãîòâîðèòåëüíî vëèÿåò è íà íåéòðîïåíèþ:
While lithium does have potential side effects, studies have demonstrated that it can cause a reversible leukocytosis and bolster neutrophil counts in both children and adults (Boshes et al., 2001, Esposito et al., 2005, Bender et al., 2004). Lithium increases ANC and total WBC count both acutely and chronically although the magnitude of effect has not been clearly determined (Lapierre and Stewart, 1980, Small et al., 2003). Previous work has supported the idea that effect is not dose related although a study by Blier and colleagues found that a lithium level of at least 0.4 may be required (Lapierre and Stewart, 1980, Blier et al., 1998). The mechanism by which lithium increases in WBC and ANC is unclear but may involve demargination (Small et al., 2003) ), stimulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) (Ozdemir et al., 1994) and stimulation of cytokines (Phiel and Klein, 2001).
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |